AAAAAA
Results:
1-7
|
Results: 7
Authors:
Ouyang, XM
Gulliford, T
Huang, GC
Harper-Wynne, C
Shousha, S
Epstein, RJ
Citation: Xm. Ouyang et al., Multisite phosphotyping of the ErbB-2 oncoprotein in human breast cancer, MOL DIAGN, 6(1), 2001, pp. 17-25
Authors:
Harper-Wynne, C
Dowsett, M
Citation: C. Harper-wynne et M. Dowsett, Recent advances in the clinical application of aromatase inhibitors, J STEROID B, 76(1-5), 2001, pp. 179-186
Authors:
Dowsett, M
Harper-Wynne, C
Boeddinghaus, I
Salter, J
Hills, M
Dixon, M
Ebbs, S
Gui, G
Sacks, N
Smith, I
Citation: M. Dowsett et al., HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer, CANCER RES, 61(23), 2001, pp. 8452-8458
Authors:
Coombes, RC
Harper-Wynne, C
Dowsett, M
Citation: Rc. Coombes et al., Aromatase inhibitors and their use in the sequential setting, ENDOCR-R CA, 6(2), 1999, pp. 259-263
Authors:
Harper-Wynne, C
Hills, MJ
Nasiri, N
Salter, J
Dowsett, M
Citation: C. Harper-wynne et al., Estimation of proliferative activity in normal postmenopausal breast tissue using core biopsy, BREAST, 8(1), 1999, pp. 35-36
Authors:
Harper-Wynne, C
Coombes, RC
Citation: C. Harper-wynne et Rc. Coombes, Anastrozole shows evidence of activity in postmenopausal patients who haveresponded or stabilised on formestane therapy, EUR J CANC, 35(5), 1999, pp. 744-746
Authors:
Harper-Wynne, C
English, J
Meyer, L
Bower, M
Archer, C
Sinnett, HD
Lowdell, C
Coombes, RC
Citation: C. Harper-wynne et al., Randomized trial to compare the efficacy and toxicity of cyclophosphamide,methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast, BR J CANC, 81(2), 1999, pp. 316-322
Risultati:
1-7
|